The global Point of Care & Rapid Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care & Rapid Diagnostics.

Report Scope

The Point of Care & Rapid Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point of Care & Rapid Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Point of Care & Rapid Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Point of Care & Rapid Diagnostics Market Report

Report Metric	Details
Report Name	Point of Care & Rapid Diagnostics Market
CAGR	5%
Segment by Type	Rapid Test Molecular Diagnostics
Segment by Application	Hospital Home Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD, Sysmex, Cardinal Health, Quidel, GE Healthcare, EKF Diagnostics, bioMérieux SA, Accubiotech, PTS Diagnostics, Chembio Diagnostics, Trinity Biotech, Sekisui Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care & Rapid Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Point of Care & Rapid Diagnostics Market report?

Ans: The main players in the Point of Care & Rapid Diagnostics Market are Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD, Sysmex, Cardinal Health, Quidel, GE Healthcare, EKF Diagnostics, bioMérieux SA, Accubiotech, PTS Diagnostics, Chembio Diagnostics, Trinity Biotech, Sekisui Diagnostics

What are the Application segmentation covered in the Point of Care & Rapid Diagnostics Market report?

Ans: The Applications covered in the Point of Care & Rapid Diagnostics Market report are Hospital, Home Care

What are the Type segmentation covered in the Point of Care & Rapid Diagnostics Market report?

Ans: The Types covered in the Point of Care & Rapid Diagnostics Market report are Rapid Test, Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Rapid Test

1.2.3 Molecular Diagnostics

1.3 Market by Application

1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Home Care

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2019-2030)

2.2 Point of Care & Rapid Diagnostics Growth Trends by Region

2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Point of Care & Rapid Diagnostics Market Dynamics

2.3.1 Point of Care & Rapid Diagnostics Industry Trends

2.3.2 Point of Care & Rapid Diagnostics Market Drivers

2.3.3 Point of Care & Rapid Diagnostics Market Challenges

2.3.4 Point of Care & Rapid Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue

3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Point of Care & Rapid Diagnostics Revenue

3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio

3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2023

3.5 Point of Care & Rapid Diagnostics Key Players Head office and Area Served

3.6 Key Players Point of Care & Rapid Diagnostics Product Solution and Service

3.7 Date of Enter into Point of Care & Rapid Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Point of Care & Rapid Diagnostics Breakdown Data by Type

4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2025-2030)

5 Point of Care & Rapid Diagnostics Breakdown Data by Application

5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Point of Care & Rapid Diagnostics Market Size (2019-2030)

6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2019-2024)

6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Point of Care & Rapid Diagnostics Market Size (2019-2030)

7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2019-2024)

7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2019-2030)

9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson and Johnson

11.1.1 Johnson and Johnson Company Detail

11.1.2 Johnson and Johnson Business Overview

11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction

11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.1.5 Johnson and Johnson Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Detail

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction

11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Bio-Techne

11.3.1 Bio-Techne Company Detail

11.3.2 Bio-Techne Business Overview

11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction

11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.3.5 Bio-Techne Recent Development

11.4 Roche Diagnostics

11.4.1 Roche Diagnostics Company Detail

11.4.2 Roche Diagnostics Business Overview

11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction

11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.4.5 Roche Diagnostics Recent Development

11.5 Siemens Healthineers

11.5.1 Siemens Healthineers Company Detail

11.5.2 Siemens Healthineers Business Overview

11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction

11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.5.5 Siemens Healthineers Recent Development

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Detail

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction

11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.6.5 Abbott Laboratories Recent Development

11.7 Danaher Corporation

11.7.1 Danaher Corporation Company Detail

11.7.2 Danaher Corporation Business Overview

11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction

11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.7.5 Danaher Corporation Recent Development

11.8 BD

11.8.1 BD Company Detail

11.8.2 BD Business Overview

11.8.3 BD Point of Care & Rapid Diagnostics Introduction

11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.8.5 BD Recent Development

11.9 Sysmex

11.9.1 Sysmex Company Detail

11.9.2 Sysmex Business Overview

11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction

11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.9.5 Sysmex Recent Development

11.10 Cardinal Health

11.10.1 Cardinal Health Company Detail

11.10.2 Cardinal Health Business Overview

11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction

11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.10.5 Cardinal Health Recent Development

11.11 Quidel

11.11.1 Quidel Company Detail

11.11.2 Quidel Business Overview

11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction

11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.11.5 Quidel Recent Development

11.12 GE Healthcare

11.12.1 GE Healthcare Company Detail

11.12.2 GE Healthcare Business Overview

11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction

11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.12.5 GE Healthcare Recent Development

11.13 EKF Diagnostics

11.13.1 EKF Diagnostics Company Detail

11.13.2 EKF Diagnostics Business Overview

11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction

11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.13.5 EKF Diagnostics Recent Development

11.14 bioMérieux SA

11.14.1 bioMérieux SA Company Detail

11.14.2 bioMérieux SA Business Overview

11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction

11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.14.5 bioMérieux SA Recent Development

11.15 Accubiotech

11.15.1 Accubiotech Company Detail

11.15.2 Accubiotech Business Overview

11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction

11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.15.5 Accubiotech Recent Development

11.16 PTS Diagnostics

11.16.1 PTS Diagnostics Company Detail

11.16.2 PTS Diagnostics Business Overview

11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction

11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.16.5 PTS Diagnostics Recent Development

11.17 Chembio Diagnostics

11.17.1 Chembio Diagnostics Company Detail

11.17.2 Chembio Diagnostics Business Overview

11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction

11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.17.5 Chembio Diagnostics Recent Development

11.18 Trinity Biotech

11.18.1 Trinity Biotech Company Detail

11.18.2 Trinity Biotech Business Overview

11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction

11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.18.5 Trinity Biotech Recent Development

11.19 Sekisui Diagnostics

11.19.1 Sekisui Diagnostics Company Detail

11.19.2 Sekisui Diagnostics Business Overview

11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction

11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024)

11.19.5 Sekisui Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Johnson and Johnson

Thermo Fisher Scientific

List of Tables

Table 1. Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Rapid Test

Table 3. Key Players of Molecular Diagnostics

Table 4. Global Point of Care & Rapid Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Point of Care & Rapid Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Point of Care & Rapid Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Point of Care & Rapid Diagnostics Market Share by Region (2019-2024)

Table 8. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Point of Care & Rapid Diagnostics Market Share by Region (2025-2030)

Table 10. Point of Care & Rapid Diagnostics Market Trends

Table 11. Point of Care & Rapid Diagnostics Market Drivers

Table 12. Point of Care & Rapid Diagnostics Market Challenges

Table 13. Point of Care & Rapid Diagnostics Market Restraints

Table 14. Global Point of Care & Rapid Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Point of Care & Rapid Diagnostics Market Share by Players (2019-2024)

Table 16. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2023)

Table 17. Ranking of Global Top Point of Care & Rapid Diagnostics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Point of Care & Rapid Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Point of Care & Rapid Diagnostics Product Solution and Service

Table 21. Date of Enter into Point of Care & Rapid Diagnostics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Point of Care & Rapid Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2019-2024)

Table 25. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Point of Care & Rapid Diagnostics Revenue Market Share by Type (2025-2030)

Table 27. Global Point of Care & Rapid Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2019-2024)

Table 29. Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Point of Care & Rapid Diagnostics Revenue Market Share by Application (2025-2030)

Table 31. North America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Point of Care & Rapid Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Point of Care & Rapid Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Point of Care & Rapid Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Point of Care & Rapid Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Point of Care & Rapid Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Point of Care & Rapid Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Point of Care & Rapid Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Johnson and Johnson Company Detail

Table 47. Johnson and Johnson Business Overview

Table 48. Johnson and Johnson Point of Care & Rapid Diagnostics Product

Table 49. Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 50. Johnson and Johnson Recent Development

Table 51. Thermo Fisher Scientific Company Detail

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific Point of Care & Rapid Diagnostics Product

Table 54. Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Bio-Techne Company Detail

Table 57. Bio-Techne Business Overview

Table 58. Bio-Techne Point of Care & Rapid Diagnostics Product

Table 59. Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 60. Bio-Techne Recent Development

Table 61. Roche Diagnostics Company Detail

Table 62. Roche Diagnostics Business Overview

Table 63. Roche Diagnostics Point of Care & Rapid Diagnostics Product

Table 64. Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 65. Roche Diagnostics Recent Development

Table 66. Siemens Healthineers Company Detail

Table 67. Siemens Healthineers Business Overview

Table 68. Siemens Healthineers Point of Care & Rapid Diagnostics Product

Table 69. Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 70. Siemens Healthineers Recent Development

Table 71. Abbott Laboratories Company Detail

Table 72. Abbott Laboratories Business Overview

Table 73. Abbott Laboratories Point of Care & Rapid Diagnostics Product

Table 74. Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 75. Abbott Laboratories Recent Development

Table 76. Danaher Corporation Company Detail

Table 77. Danaher Corporation Business Overview

Table 78. Danaher Corporation Point of Care & Rapid Diagnostics Product

Table 79. Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 80. Danaher Corporation Recent Development

Table 81. BD Company Detail

Table 82. BD Business Overview

Table 83. BD Point of Care & Rapid Diagnostics Product

Table 84. BD Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 85. BD Recent Development

Table 86. Sysmex Company Detail

Table 87. Sysmex Business Overview

Table 88. Sysmex Point of Care & Rapid Diagnostics Product

Table 89. Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 90. Sysmex Recent Development

Table 91. Cardinal Health Company Detail

Table 92. Cardinal Health Business Overview

Table 93. Cardinal Health Point of Care & Rapid Diagnostics Product

Table 94. Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 95. Cardinal Health Recent Development

Table 96. Quidel Company Detail

Table 97. Quidel Business Overview

Table 98. Quidel Point of Care & Rapid Diagnostics Product

Table 99. Quidel Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 100. Quidel Recent Development

Table 101. GE Healthcare Company Detail

Table 102. GE Healthcare Business Overview

Table 103. GE Healthcare Point of Care & Rapid Diagnostics Product

Table 104. GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 105. GE Healthcare Recent Development

Table 106. EKF Diagnostics Company Detail

Table 107. EKF Diagnostics Business Overview

Table 108. EKF Diagnostics Point of Care & Rapid Diagnostics Product

Table 109. EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 110. EKF Diagnostics Recent Development

Table 111. bioMérieux SA Company Detail

Table 112. bioMérieux SA Business Overview

Table 113. bioMérieux SA Point of Care & Rapid Diagnostics Product

Table 114. bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 115. bioMérieux SA Recent Development

Table 116. Accubiotech Company Detail

Table 117. Accubiotech Business Overview

Table 118. Accubiotech Point of Care & Rapid Diagnostics Product

Table 119. Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 120. Accubiotech Recent Development

Table 121. PTS Diagnostics Company Detail

Table 122. PTS Diagnostics Business Overview

Table 123. PTS Diagnostics Point of Care & Rapid Diagnostics Product

Table 124. PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 125. PTS Diagnostics Recent Development

Table 126. Chembio Diagnostics Company Detail

Table 127. Chembio Diagnostics Business Overview

Table 128. Chembio Diagnostics Point of Care & Rapid Diagnostics Product

Table 129. Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 130. Chembio Diagnostics Recent Development

Table 131. Trinity Biotech Company Detail

Table 132. Trinity Biotech Business Overview

Table 133. Trinity Biotech Point of Care & Rapid Diagnostics Product

Table 134. Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 135. Trinity Biotech Recent Development

Table 136. Sekisui Diagnostics Company Detail

Table 137. Sekisui Diagnostics Business Overview

Table 138. Sekisui Diagnostics Point of Care & Rapid Diagnostics Product

Table 139. Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2019-2024) & (US$ Million)

Table 140. Sekisui Diagnostics Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Point of Care & Rapid Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Point of Care & Rapid Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Rapid Test Features

Figure 4. Molecular Diagnostics Features

Figure 5. Global Point of Care & Rapid Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Point of Care & Rapid Diagnostics Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Home Care Case Studies

Figure 9. Point of Care & Rapid Diagnostics Report Years Considered

Figure 10. Global Point of Care & Rapid Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Point of Care & Rapid Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Point of Care & Rapid Diagnostics Market Share by Region: 2023 VS 2030

Figure 13. Global Point of Care & Rapid Diagnostics Market Share by Players in 2023

Figure 14. Global Top Point of Care & Rapid Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Point of Care & Rapid Diagnostics Revenue in 2023

Figure 16. North America Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Point of Care & Rapid Diagnostics Market Share by Country (2019-2030)

Figure 18. United States Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Point of Care & Rapid Diagnostics Market Share by Country (2019-2030)

Figure 22. Germany Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Point of Care & Rapid Diagnostics Market Share by Region (2019-2030)

Figure 30. China Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Point of Care & Rapid Diagnostics Market Share by Country (2019-2030)

Figure 38. Mexico Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Point of Care & Rapid Diagnostics Market Share by Country (2019-2030)

Figure 42. Turkey Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Point of Care & Rapid Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Johnson and Johnson Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 46. Bio-Techne Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 47. Roche Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 48. Siemens Healthineers Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 49. Abbott Laboratories Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 50. Danaher Corporation Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 51. BD Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 52. Sysmex Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 53. Cardinal Health Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 54. Quidel Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 55. GE Healthcare Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 56. EKF Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 57. bioMérieux SA Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 58. Accubiotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 59. PTS Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 60. Chembio Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 61. Trinity Biotech Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 62. Sekisui Diagnostics Revenue Growth Rate in Point of Care & Rapid Diagnostics Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-18U13002

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Triple X Syndrome Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19Q13375

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global In Vivo Biosafety Testing Services Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27L14412

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global 3D Computed Tomography Software Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9O10905

Thu Oct 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Point of Care & Rapid Diagnostics Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-10I13031

Global Point of Care & Rapid Diagnostics Market Research Report 2024

FEATURED COMPANIES

Point of Care & Rapid Diagnostics Market Size

Point of Care & Rapid Diagnostics Market

Report Scope

Scope of Point of Care & Rapid Diagnostics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Point of Care & Rapid Diagnostics Market report?

What are the Application segmentation covered in the Point of Care & Rapid Diagnostics Market report?

What are the Type segmentation covered in the Point of Care & Rapid Diagnostics Market report?

FEATURED COMPANIES

RELATED REPORTS